edgen-logoBeta

Chat with Ed

Brief

Invest
Plan

Track
Others

Discover

Referral

Subscriptions


Back


healthcare: biotechNews

MarketsEconomyTech & AIEnergyHealthcareHK & ChinaFinance

Pharma

Biotech

Health Services

Medical Devices

Viking Therapeutics raises $400 million as VKTX dilution risk builds

Viking Therapeutics raises $400 million as VKTX dilution risk builds

Sep 23 2026, 21:02
Wave Life Sciences starts Phase 2a obesity trial pairing WVE-007 with tirzepatide

Wave Life Sciences starts Phase 2a obesity trial pairing WVE-007 with tirzepatide

Sep 23 2026, 13:29
Artelo files obesity patent after ART27.13 matches semaglutide in mice

Artelo files obesity patent after ART27.13 matches semaglutide in mice

Sep 23 2026, 13:25
Ionis falls 40% in 2026 while analysts hold $83.82 target

Ionis falls 40% in 2026 while analysts hold $83.82 target

Sep 20 2026, 14:26
Twist Bioscience jumps 7% as Lilly AI data deal pays revenue

Twist Bioscience jumps 7% as Lilly AI data deal pays revenue

Sep 19 2026, 00:29
Intellia wins FDA priority review with 2027 decision date

Intellia wins FDA priority review with 2027 decision date

Sep 18 2026, 14:58
FDA approves first Sanfilippo A gene therapy, crediting Abeona's out-licensed work

FDA approves first Sanfilippo A gene therapy, crediting Abeona's out-licensed work

Sep 18 2026, 11:56
Halozyme prices $1.3B convertible at 1.50% to retire 2027 notes

Halozyme prices $1.3B convertible at 1.50% to retire 2027 notes

Sep 18 2026, 04:44
Corbus obesity pill cuts 5% of weight in 12 weeks

Corbus obesity pill cuts 5% of weight in 12 weeks

Sep 15 2026, 10:21
Tenaya wins FDA RMAT tag for TN-401 in 70,000-patient ARVC

Tenaya wins FDA RMAT tag for TN-401 in 70,000-patient ARVC

Sep 14 2026, 12:59
NRx wins European patent for ALS drug GNK-301

NRx wins European patent for ALS drug GNK-301

Sep 14 2026, 11:37
Cellectis pivots to in vivo editing with cash runway to 2028

Cellectis pivots to in vivo editing with cash runway to 2028

Sep 14 2026, 10:12
Prelude wins FDA clearance for first KAT6A degrader trial

Prelude wins FDA clearance for first KAT6A degrader trial

Sep 10 2026, 11:40
Verastem surges 121% as VS-7375 data readout nears

Verastem surges 121% as VS-7375 data readout nears

Sep 08 2026, 15:30
Viking Therapeutics trades below targets as VK2735 oral safety questioned

Viking Therapeutics trades below targets as VK2735 oral safety questioned

Sep 06 2026, 00:57
Zorevunersen 4-year data bolster Dravet case ahead of 2027 readout

Zorevunersen 4-year data bolster Dravet case ahead of 2027 readout

Sep 03 2026, 23:55
Oxford BioMedica falls 15% as CAR-T trial pauses hit manufacturing

Oxford BioMedica falls 15% as CAR-T trial pauses hit manufacturing

Sep 02 2026, 12:53
Moderna stock surges 127% as cancer vaccine reshapes biotech outlook

Moderna stock surges 127% as cancer vaccine reshapes biotech outlook

Aug 30 2026, 17:52
Oruka Therapeutics jumps 65% on psoriasis drug trial momentum

Oruka Therapeutics jumps 65% on psoriasis drug trial momentum

Aug 28 2026, 16:31
BioNTech drops 6.6% after halting colorectal cancer vaccine trial

BioNTech drops 6.6% after halting colorectal cancer vaccine trial

Aug 28 2026, 16:21

Feature
Financial Fitness
Pricing
Guides
What is a Money Person
What is Financial Fitness
RSU vested money tool
Are you behind on retirement savings
Check-up
Financial Fitness Check
Money Personality
Will You Be a Billionaire
Terms of UsePrivacy Policy
© 2026 Finture Development Limited (EdWealth). All rights reserved.